Not exact matches
There are also forums dedicated to
policy issues such as drug pricing
and medical standards — last year, former Vice President Joe Biden announced a federal
Genomic Data Commons to expedite cancer
research during a keynote address.
2) As part of the ESRC Genomics Network (EGN), the Forum acts to: integrate the diverse strands of social science
research within
and beyond the EGN; develop links between social scientists
and scientists working across the entire range of
genomic science
and technology; connect
research in this area to
policy makers, business, the media
and civil society in the UK
and abroad.
This is a fellowship program designed for genetics professionals with an advanced degree who are early in their careers
and interested in the development
and implementation of national
genomics literacy efforts, informal science education, science education
policy, program development, or science education
research.
Knowledge brokering is different in that it creates «an ongoing dialogue
and exchange» between researchers
and stakeholders, explains Christine Knight, a
policy research fellow at the Economic and Social Research Council Genomics Policy and Research Forum in Edinburgh, U.K. Knight works as a knowledge broker — among genomics researchers, social scientists, and policy makers — and as a social scientist studying knowledge brokering roles in the United Ki
policy research fellow at the Economic and Social Research Council Genomics Policy and Research Forum in Edinburgh, U.K. Knight works as a knowledge broker — among genomics researchers, social scientists, and policy makers — and as a social scientist studying knowledge brokering roles in the United
research fellow at the Economic
and Social
Research Council Genomics Policy and Research Forum in Edinburgh, U.K. Knight works as a knowledge broker — among genomics researchers, social scientists, and policy makers — and as a social scientist studying knowledge brokering roles in the United
Research Council
Genomics Policy and Research Forum in Edinburgh, U.K. Knight works as a knowledge broker — among genomics researchers, social scientists, and policy makers — and as a social scientist studying knowledge brokering roles in the United Ki
Policy and Research Forum in Edinburgh, U.K. Knight works as a knowledge broker — among genomics researchers, social scientists, and policy makers — and as a social scientist studying knowledge brokering roles in the United
Research Forum in Edinburgh, U.K. Knight works as a knowledge broker — among
genomics researchers, social scientists,
and policy makers — and as a social scientist studying knowledge brokering roles in the United Ki
policy makers —
and as a social scientist studying knowledge brokering roles in the United Kingdom.
They do social science, health, philosophical,
policy, or legal
research on topics such as privacy, confidentiality, the psychological impact of genetic information, informed - consent issues in
genomics research, commercialization of genetic products, genetically modified foods, behavioral genetics, gene testing,
and gene therapy.
«Advances in DNA sequencing technologies have enabled NIH to conduct
and fund
research that generates ever - greater volumes of GWAS
and other types of
genomic data,» said Eric Green, M.D., Ph.D., NHGRI director, report co-author
and a co-chair of the trans - NIH committee that developed the GDS
policy.
The National Institutes of Health has issued a final NIH
Genomic Data Sharing (GDS)
policy to promote data sharing as a way to speed the translation of data into knowledge, products
and procedures that improve health while protecting the privacy of
research participants.
«My goal as chief is to position NHGRI's
policy shop as the top resource on
genomics research and related
policy issues for both
policy makers
and grantees.»
The branch also serves as an informational resource
and liaison for parties interested in
policy matters related to human genetics
and genomics research.
Founded by J. Craig Venter, Ph.D., the JCVI is home to approximately 300 scientists
and staff with expertise in human
and evolutionary biology, genetics, bioinformatics / informatics, information technology, high - throughput DNA sequencing,
genomic and environmental
policy research,
and public education in science.
Topics covered include embryonic stem cells, pluripotency, germline stem cells, tissue - specific stem cells, stem cell differentiation, epigenetics, stem cell
genomics and systems biology, genome reprogramming, cancer stem cells, stem cell niches, stem - cell - based disease models, nuclear transfer technology, bioengineering, drug discovery, in vivo imaging of stem cells, therapeutic applications, regenerative medicine, clinical
and translational insights, stem cell
research policies, ethical issues,
and technical or resource - based innovations.
The extent to which the discoveries from genetics
and genomics research are translated into the improved health of the American people is greatly influenced by
policy decisions guiding
research and the integration of genetics
and genomics tools in the clinical setting.
Policy makers, scientists,
and private citizens around the world who are interested in
genomic research are discussing complex issues regarding ethics, social identity,
and personal health.
The CEER program, established in 2004, is designed to bring together experts in wide - ranging fields - bioethics, law, behavioral
and social sciences, epidemiology, public health, public
policy,
genomics and clinical
research - to study the potential societal implications of
genomic information
and research.